Insider Transactions in Q2 2022 at Brooklyn Immuno Therapeutics, Inc. (BTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2022
|
Kevin D Amour Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,077
-34.58%
|
$0
$0.55 P/Share
|
|
Jun 28
2022
|
Kevin D Amour Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,573
+50.0%
|
-
|
|
Jun 21
2022
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
3,586
-21.15%
|
$0
$0.48 P/Share
|
|
Jun 21
2022
|
Sandra M Gurrola Sr. VP of Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+34.04%
|
-
|